Platelet Membrane-Coated HGF-PLGA Nanoparticles Promote Therapeutic Angiogenesis and Tissue Perfusion Recovery in Ischemic Hindlimbs

Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth factor (HGF) has been identified as a key promoter of therapeutic angiogenesis, its clinical application is limited due to its short half-life. I...

Full description

Saved in:
Bibliographic Details
Published inACS applied bio materials Vol. 8; no. 1; pp. 399 - 409
Main Authors Wang, Peng, Di, Xiao, Li, Fengshi, Rong, Zhihua, Lian, Wenzhuo, Li, Zongshu, Chen, Tianqi, Wang, Wenjing, Zhong, Qing, Sun, Guoqiang, Ni, Leng, Liu, ChangWei
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 20.01.2025
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth factor (HGF) has been identified as a key promoter of therapeutic angiogenesis, its clinical application is limited due to its short half-life. In this study, we successfully developed and characterized platelet membrane-coated HGF-poly­(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs). These nanoparticles demonstrated enhanced capabilities to promote endothelial cell (EC) proliferation, migration, and tube formation in vitro. Additionally, their efficacy in improving tissue perfusion and promoting angiogenesis was confirmed in a hindlimb ischemia rat model. Our findings suggest that platelet membrane-coated HGF-PLGA-NPs could serve as a promising therapeutic approach for enhancing angiogenesis and restoring tissue perfusion in ischemic conditions.
AbstractList Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth factor (HGF) has been identified as a key promoter of therapeutic angiogenesis, its clinical application is limited due to its short half-life. In this study, we successfully developed and characterized platelet membrane-coated HGF-poly(lactic- -glycolic acid) (PLGA) nanoparticles (NPs). These nanoparticles demonstrated enhanced capabilities to promote endothelial cell (EC) proliferation, migration, and tube formation in vitro. Additionally, their efficacy in improving tissue perfusion and promoting angiogenesis was confirmed in a hindlimb ischemia rat model. Our findings suggest that platelet membrane-coated HGF-PLGA-NPs could serve as a promising therapeutic approach for enhancing angiogenesis and restoring tissue perfusion in ischemic conditions.
Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth factor (HGF) has been identified as a key promoter of therapeutic angiogenesis, its clinical application is limited due to its short half-life. In this study, we successfully developed and characterized platelet membrane-coated HGF-poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs). These nanoparticles demonstrated enhanced capabilities to promote endothelial cell (EC) proliferation, migration, and tube formation in vitro. Additionally, their efficacy in improving tissue perfusion and promoting angiogenesis was confirmed in a hindlimb ischemia rat model. Our findings suggest that platelet membrane-coated HGF-PLGA-NPs could serve as a promising therapeutic approach for enhancing angiogenesis and restoring tissue perfusion in ischemic conditions.Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth factor (HGF) has been identified as a key promoter of therapeutic angiogenesis, its clinical application is limited due to its short half-life. In this study, we successfully developed and characterized platelet membrane-coated HGF-poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs). These nanoparticles demonstrated enhanced capabilities to promote endothelial cell (EC) proliferation, migration, and tube formation in vitro. Additionally, their efficacy in improving tissue perfusion and promoting angiogenesis was confirmed in a hindlimb ischemia rat model. Our findings suggest that platelet membrane-coated HGF-PLGA-NPs could serve as a promising therapeutic approach for enhancing angiogenesis and restoring tissue perfusion in ischemic conditions.
Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth factor (HGF) has been identified as a key promoter of therapeutic angiogenesis, its clinical application is limited due to its short half-life. In this study, we successfully developed and characterized platelet membrane-coated HGF-poly­(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs). These nanoparticles demonstrated enhanced capabilities to promote endothelial cell (EC) proliferation, migration, and tube formation in vitro. Additionally, their efficacy in improving tissue perfusion and promoting angiogenesis was confirmed in a hindlimb ischemia rat model. Our findings suggest that platelet membrane-coated HGF-PLGA-NPs could serve as a promising therapeutic approach for enhancing angiogenesis and restoring tissue perfusion in ischemic conditions.
Author Wang, Peng
Li, Fengshi
Rong, Zhihua
Liu, ChangWei
Chen, Tianqi
Zhong, Qing
Di, Xiao
Li, Zongshu
Ni, Leng
Wang, Wenjing
Lian, Wenzhuo
Sun, Guoqiang
AuthorAffiliation Department of Vascular Surgery
Biomedical Engineering Facility of National Infrastructures for Translational Medicine, Institute of Clinical Medicine
Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College
Laboratory Animal Research Facility, National Infrastructures for Translational Medicine, Institute of Clinical Medicine
Department of Information Center
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
AuthorAffiliation_xml – name: Laboratory Animal Research Facility, National Infrastructures for Translational Medicine, Institute of Clinical Medicine
– name: Biomedical Engineering Facility of National Infrastructures for Translational Medicine, Institute of Clinical Medicine
– name: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
– name: Department of Information Center
– name: Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College
– name: Department of Vascular Surgery
Author_xml – sequence: 1
  givenname: Peng
  orcidid: 0000-0003-4176-2565
  surname: Wang
  fullname: Wang, Peng
  organization: Department of Vascular Surgery
– sequence: 2
  givenname: Xiao
  surname: Di
  fullname: Di, Xiao
  organization: Department of Vascular Surgery
– sequence: 3
  givenname: Fengshi
  surname: Li
  fullname: Li, Fengshi
  organization: Department of Vascular Surgery
– sequence: 4
  givenname: Zhihua
  surname: Rong
  fullname: Rong, Zhihua
  organization: Department of Vascular Surgery
– sequence: 5
  givenname: Wenzhuo
  surname: Lian
  fullname: Lian, Wenzhuo
  organization: Department of Vascular Surgery
– sequence: 6
  givenname: Zongshu
  surname: Li
  fullname: Li, Zongshu
  organization: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
– sequence: 7
  givenname: Tianqi
  surname: Chen
  fullname: Chen, Tianqi
  organization: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
– sequence: 8
  givenname: Wenjing
  surname: Wang
  fullname: Wang, Wenjing
  organization: Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College
– sequence: 9
  givenname: Qing
  surname: Zhong
  fullname: Zhong, Qing
  organization: Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
– sequence: 10
  givenname: Guoqiang
  surname: Sun
  fullname: Sun, Guoqiang
  organization: Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College
– sequence: 11
  givenname: Leng
  surname: Ni
  fullname: Ni, Leng
  email: pumchnileng@gmail.com
  organization: Department of Vascular Surgery
– sequence: 12
  givenname: ChangWei
  surname: Liu
  fullname: Liu, ChangWei
  email: liucw@vip.sina.com
  organization: Department of Vascular Surgery
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39723905$$D View this record in MEDLINE/PubMed
BookMark eNp1kUtrGzEUhUVJaR7NtsuiZSmMq-c8lsYkdsBtTXHXQiPdSRRmJFfSFLLvD6-CHSiFrO7l8J0L95xLdOaDB4Q-ULKghNEv2iTdTwthCOUNf4MumGzqqhaMnf2zn6PrlB4JIYwQTtvuHTrnXcN4R-QF-rMbdYYRMv4KUx-1h2oVimLxZn1b7bbrJf6mfTjomJ0ZIeFdDFPIgPcPEPUB5iLjpb934R48JJew9hbvXUoz4B3EYU4uePwDTPgN8Qk7j--SeYCp2DbO29FNfXqP3g56THB9mlfo5-3NfrWptt_Xd6vlttKck1xJ1ja1ZmxoW2EJsdRaWgPrapCSmaGk0AvCGUiwnSSNFd3QakGGoe-p6YzmV-jT8e4hhl8zpKwmlwyMY3k7zElxKjopiJS0oB9P6NxPYNUhuknHJ_WSXAHEETAxpBRhUMZlncuzOWo3KkrUc0fq2JE6dVRsi_9sL5dfNXw-GoquHsMcfUnoNfgvYG6jqw
CitedBy_id crossref_primary_10_3390_ijms26062386
Cites_doi 10.1002/adma.201706759
10.1038/gt.2010.101
10.1016/j.ahj.2022.08.007
10.1016/j.biomaterials.2017.02.041
10.1039/D0NR08492A
10.1038/mt.2008.33
10.1016/S0140-6736(96)03361-2
10.1002/sstr.202000018
10.1371/journal.pone.0038776
10.1186/s13073-023-01250-y
10.1172/JCI113334
10.1093/oxfordjournals.jbchem.a021283
10.1007/s13346-024-01577-y
10.1016/j.jconrel.2020.08.030
10.1161/01.ATV.0000048701.86621.D0
10.1016/j.nano.2018.08.002
10.1111/j.1440-1746.2010.06549.x
10.1016/j.vph.2012.02.002
10.2183/pjab.86.588
10.3389/fimmu.2020.02135
10.1016/j.jvs.2019.02.016
10.1093/eurheartj/ehx095
10.1089/hum.2017.217
10.1016/j.jacc.2018.03.008
10.2147/IJN.S452989
10.1039/D0NR08440A
10.1021/acsnano.7b07720
10.2147/IJN.S214727
10.3389/fendo.2020.00062
10.1186/1479-5876-9-55
10.1021/acsami.3c18464
10.1038/nature15373
10.2147/IJN.S423186
10.1016/j.isci.2022.105147
10.1016/j.apsb.2017.12.002
ContentType Journal Article
Copyright 2024 The Authors. Published by American Chemical Society
Copyright_xml – notice: 2024 The Authors. Published by American Chemical Society
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1021/acsabm.4c01373
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
EISSN 2576-6422
EndPage 409
ExternalDocumentID 39723905
10_1021_acsabm_4c01373
c697706203
Genre Journal Article
GroupedDBID 53G
ABQRX
ABUCX
ACS
AHGAQ
ALMA_UNASSIGNED_HOLDINGS
BAANH
CUPRZ
EBS
GGK
VF5
VG9
AAYXX
ABBLG
ABJNI
ABLBI
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-a330t-52876a22f884d00d1dd16e296e552cfc01b4032e5ed9507d49f8a40ffbb1c9ca3
IEDL.DBID ACS
ISSN 2576-6422
IngestDate Fri Jul 11 04:26:20 EDT 2025
Mon Jul 21 05:47:37 EDT 2025
Sun Jul 06 05:03:42 EDT 2025
Thu Apr 24 22:56:24 EDT 2025
Tue Jan 21 04:03:37 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords therapeutic angiogenesis
peripheral artery disease
drug delivery
chronic limb-threatening ischemia
hepatocyte growth factor
Language English
License https://doi.org/10.15223/policy-029
https://creativecommons.org/licenses/by-nc-nd/4.0
https://doi.org/10.15223/policy-045
https://doi.org/10.15223/policy-037
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a330t-52876a22f884d00d1dd16e296e552cfc01b4032e5ed9507d49f8a40ffbb1c9ca3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-4176-2565
PMID 39723905
PQID 3149540551
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_3149540551
pubmed_primary_39723905
crossref_citationtrail_10_1021_acsabm_4c01373
crossref_primary_10_1021_acsabm_4c01373
acs_journals_10_1021_acsabm_4c01373
PublicationCentury 2000
PublicationDate 2025-01-20
PublicationDateYYYYMMDD 2025-01-20
PublicationDate_xml – month: 01
  year: 2025
  text: 2025-01-20
  day: 20
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle ACS applied bio materials
PublicationTitleAlternate ACS Appl. Bio Mater
PublicationYear 2025
Publisher American Chemical Society
Publisher_xml – name: American Chemical Society
References ref9/cit9
ref6/cit6
ref3/cit3
ref27/cit27
ref18/cit18
ref11/cit11
ref25/cit25
ref16/cit16
ref29/cit29
ref32/cit32
ref23/cit23
ref14/cit14
ref8/cit8
ref5/cit5
ref31/cit31
ref2/cit2
ref34/cit34
ref28/cit28
ref20/cit20
ref17/cit17
ref10/cit10
ref26/cit26
ref35/cit35
ref19/cit19
ref21/cit21
ref12/cit12
ref15/cit15
ref22/cit22
ref13/cit13
ref33/cit33
ref4/cit4
ref30/cit30
ref1/cit1
ref24/cit24
ref7/cit7
References_xml – ident: ref16/cit16
  doi: 10.1002/adma.201706759
– ident: ref5/cit5
  doi: 10.1038/gt.2010.101
– ident: ref6/cit6
  doi: 10.1016/j.ahj.2022.08.007
– ident: ref17/cit17
  doi: 10.1016/j.biomaterials.2017.02.041
– ident: ref18/cit18
  doi: 10.1039/D0NR08492A
– ident: ref7/cit7
  doi: 10.1038/mt.2008.33
– ident: ref4/cit4
  doi: 10.1016/S0140-6736(96)03361-2
– ident: ref20/cit20
  doi: 10.1002/sstr.202000018
– ident: ref35/cit35
  doi: 10.1371/journal.pone.0038776
– ident: ref28/cit28
  doi: 10.1186/s13073-023-01250-y
– ident: ref32/cit32
  doi: 10.1172/JCI113334
– ident: ref31/cit31
  doi: 10.1093/oxfordjournals.jbchem.a021283
– ident: ref13/cit13
  doi: 10.1007/s13346-024-01577-y
– ident: ref26/cit26
  doi: 10.1016/j.jconrel.2020.08.030
– ident: ref9/cit9
  doi: 10.1161/01.ATV.0000048701.86621.D0
– ident: ref34/cit34
  doi: 10.1016/j.nano.2018.08.002
– ident: ref33/cit33
  doi: 10.1111/j.1440-1746.2010.06549.x
– ident: ref12/cit12
  doi: 10.1016/j.vph.2012.02.002
– ident: ref11/cit11
  doi: 10.2183/pjab.86.588
– ident: ref10/cit10
  doi: 10.3389/fimmu.2020.02135
– ident: ref2/cit2
  doi: 10.1016/j.jvs.2019.02.016
– ident: ref1/cit1
  doi: 10.1093/eurheartj/ehx095
– ident: ref8/cit8
  doi: 10.1089/hum.2017.217
– ident: ref3/cit3
  doi: 10.1016/j.jacc.2018.03.008
– ident: ref15/cit15
  doi: 10.2147/IJN.S452989
– ident: ref19/cit19
  doi: 10.1039/D0NR08440A
– ident: ref25/cit25
  doi: 10.1021/acsnano.7b07720
– ident: ref22/cit22
  doi: 10.2147/IJN.S214727
– ident: ref29/cit29
  doi: 10.3389/fendo.2020.00062
– ident: ref30/cit30
  doi: 10.1186/1479-5876-9-55
– ident: ref14/cit14
  doi: 10.1021/acsami.3c18464
– ident: ref21/cit21
  doi: 10.1038/nature15373
– ident: ref24/cit24
  doi: 10.2147/IJN.S423186
– ident: ref23/cit23
  doi: 10.1016/j.isci.2022.105147
– ident: ref27/cit27
  doi: 10.1016/j.apsb.2017.12.002
SSID ssj0002003189
Score 2.2945104
Snippet Therapeutic angiogenesis has garnered significant attention as a potential treatment strategy for lower limb ischemic diseases. Although hepatocyte growth...
SourceID proquest
pubmed
crossref
acs
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 399
SubjectTerms Angiogenesis
Animals
Biocompatible Materials - chemistry
Biocompatible Materials - pharmacology
Blood Platelets - chemistry
Cell Movement - drug effects
Cell Proliferation - drug effects
Hepatocyte Growth Factor - chemistry
Hepatocyte Growth Factor - pharmacology
Hindlimb - blood supply
Hindlimb - drug effects
Humans
Ischemia - drug therapy
Male
Materials Testing
Nanoparticles - chemistry
Neovascularization, Physiologic - drug effects
Particle Size
Polylactic Acid-Polyglycolic Acid Copolymer - chemistry
Polylactic Acid-Polyglycolic Acid Copolymer - pharmacology
Rats
Rats, Sprague-Dawley
Surface Properties
Title Platelet Membrane-Coated HGF-PLGA Nanoparticles Promote Therapeutic Angiogenesis and Tissue Perfusion Recovery in Ischemic Hindlimbs
URI http://dx.doi.org/10.1021/acsabm.4c01373
https://www.ncbi.nlm.nih.gov/pubmed/39723905
https://www.proquest.com/docview/3149540551
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1LbxMxELZKuMChQHmlLxkViZPDrr3ex3EVkaQIqpVIpNxWfqKIZFN1k0N77g9n7N2kpVVErytr5PWMPd9njz8j9DnhcZJBaibackEiY0IiQ5MQqwArM0kB1Hm1z4t4NIm-T_n0br_j4Qk-Db8KVQu56EXKieOxZ-g5jdPE0ay8_2u7m0J9cDqs6wA0AVBNNwqNj0y4PKTqf_PQDnDpk8zgVaN4VHttQldb8qe3Xsmeunms3Pjf_r9G-y3SxHkTGm_QnqkO0Mt7-oNv0W0xB6gJnsM_zQJoc2VIfwlfNB4NB6T4McwxrL5Aq9vqOVz44j2Dx3e3tnAOFpe_3ZI5q7GoNB57X-LCXNm124vDjuLCjLnGswqfA5t29fh4NKv0fLaQ9Ts0GXwb90ekfZaBCMaCFVBXWEEFpTZNIx0EOtQ6jA3NYsM5VRb-U0YBo4YbnQHa1FFmUxEF1koZqkwJ9h51qmVlPiJsmTJBalzpChC7lEqqGQ9kwoXNwHrcRWcwfGU7rerSn5jTsGzGtGzHtIvIxpWlapXN3QMb853tv2zbXzaaHjtbftpERgnTzp2lgCuW67pkjlkC2OVhF31oQmZri7mX3LKAHz6p90foBXVXKnxR4THqrK7W5gSAzkqe-hj_C5Rw-GU
linkProvider American Chemical Society
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV1Lb9NAEB6VcgAOlDdpeSwCxGmDvfY69oFDFEgdmlaRSKXeXO-riprYVZ2oKmf-B3-Fn8bsxk55KBKXSlxXq9FqZ2bnm93ZbwDedHjUSTA0U2V4TkOtfSp83aFGIlYOBENQ59g-D6L0MPx8xI824HvzFwYXUaGkyj3iX7EL-O9xLBezdigtR17TrXpPX15gjlZ9GHxEhb5lrP9p3Etp3UaA5piszzHVQo_PGTNxHCrPU75SfqRZEmnOmTQoUIRewDTXKkF0pMLExHnoGSOELxOZByj3BtxE5MNsdtftfVld4jDnExZiW9xOEcuzhhjyryXb8Cer38PfGkzrYlt_C36sdsWVtJy2F3PRll__IIz8j7ftHtytcTXpLh3hPmzo4gHc-YVt8SF8G00RWKOdkn09ExijNe2VOKJIutuno-Ful2CsKc-aWkEycqWKmoyv_qiRLkosT2yAmFQkLxQZO8slI31uFvbmkdiEHs-HSzIpyKCSjpCBpJNCTSczUT2Cw2vZhsewWZSFfgrEBFJ7sbaFOpjGxkwwFXBPdHhuEpQeteA1qiurD5Eqc_UBzM-WOsxqHbaANhaUyZrH3bYTma6d_241_2zJYLJ25qvGIDM8ZOzLEaqiXFRZYPNohPbcb8GTpaWuZAW2b13i8e1_Wv1LuJWO94fZcHCwtwO3me2m7Pl4Vj-Dzfn5Qj9HiDcXL5ybETi-bgP9CZW4Wxk
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzV1Lj9MwEB4ti4TgwPtRnkaAOLnETpwmBw5Vl27LLqtIdKW9hfiFKtqk2rRCy5l_wl_hhzF2k_JSJS4rcbWskeWZ8Xxjj78BeN4TcS_F0Ey1FQWNjGFUMtOjViFWDiVHUOfZPo_i0XH09kSc7MC39i8MLqJGSbV_xHdevdC2YRhgr3C8kPNupBxPXtux-sCcfcY8rX493kOlvuB8-GYyGNGmlQAtMGFfYrqFXl9wbpMk0kGgmdYsNjyNjRBcWRQooyDkRhidIkLSUWqTIgqslZKpVBUhyr0AF90bocvw-oP3m4sc7v3CwWyH3Snied6SQ_61ZBcCVf17CNyCa318G16D75ud8WUtn7qrpeyqL3-QRv7nW3cdrjb4mvTXDnEDdkx5E678wrp4C75mMwTYaK_knZlLjNWGDioc0WS0P6TZ4X6fYMypFm3NIMl8yaIhk59_1UgfJVYfXaCY1qQoNZl4CyaZObUrdwNJXGKP58QZmZZkXCtPzEBG01LPpnNZ34bjc9mGO7BbVqW5B8SGygSJcQU7mM4mXHIdikD2RGFTlB534BmqK28Okzr3dQKc5Wsd5o0OO0BbK8pVw-fu2orMts5_uZm_WDOZbJ35tDXKHA8b94KEqqhWdR66fBohvmAduLu21o2s0PWvSwNx_59W_wQuZXvD_HB8dPAALnPXVDlgeGQ_hN3l6co8QqS3lI-9pxH4cN72-QMCoV2c
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Platelet+Membrane-Coated+HGF-PLGA+Nanoparticles+Promote+Therapeutic+Angiogenesis+and+Tissue+Perfusion+Recovery+in+Ischemic+Hindlimbs&rft.jtitle=ACS+applied+bio+materials&rft.au=Wang%2C+Peng&rft.au=Di%2C+Xiao&rft.au=Li%2C+Fengshi&rft.au=Rong%2C+Zhihua&rft.date=2025-01-20&rft.issn=2576-6422&rft.eissn=2576-6422&rft.volume=8&rft.issue=1&rft.spage=399&rft.epage=409&rft_id=info:doi/10.1021%2Facsabm.4c01373&rft.externalDBID=n%2Fa&rft.externalDocID=10_1021_acsabm_4c01373
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2576-6422&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2576-6422&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2576-6422&client=summon